Cytotoxic T lymphocytes as immune-therapy in haematological practice

Ann M. Leen, Helen E. Heslop

Research output: Contribution to journalReview article

32 Scopus citations

Abstract

Viral infections are a significant cause of morbidity and mortality, particularly in pediatric allogeneic haematopoietic stem cell transplant recipients. Effective therapies are limited and often associated with significant side effects. Adoptive transfer of virus-reactive T cells offers a means of reconstituting antiviral immunity and this approach has been successfully used to prevent and treat cytomegalovirus, Epstein-Barr virus, and adenovirus infections in vivo. This review outlines the clinical trials that have been performed to date, and will describe future initiatives to (a) develop strategies that can increase the breadth of the viruses that can be targeted, and (b) simplify the process to extend this technology to more centers so that cellular therapy to reconstitute immunity can be more widely applied.

Original languageEnglish (US)
Pages (from-to)169-179
Number of pages11
JournalBritish Journal of Haematology
Volume143
Issue number2
DOIs
StatePublished - Oct 2008

Keywords

  • Immunotherapy
  • Stem cell transplantation
  • T cells
  • Viruses

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Cytotoxic T lymphocytes as immune-therapy in haematological practice'. Together they form a unique fingerprint.

Cite this